Premature Ventricular Complexes
11
5
5
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.1%
1 terminated out of 11 trials
66.7%
-19.9% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (11)
Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes
Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation
Sustained Auricular Nerve Stimulation for PVC Suppression
Physical Impairments in Premature Ventricular Complex
TAES for FPVCs: a Pragmatic, Randomized Controlled Trial
Flecainide in Idiopathic Premature Ventricular Contractions and Related Cardiomyopathy
Transcutaneous Vagus Nerve Stimulation for Ventricular Arrhythmias
Impact of Catheter Ablation of Frequent Premature Ventricular Complexes in Treating Subtle Left Cardiomyopathy
WHEN DO WE HAVE to PERFORM CARDIAC MAGNETIC RESONANCE in PATIENTS REFERRED for PREMATURE VENTRICULAR COMPLEXES by THEIR CARDIOLOGISTS
A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
Optimal EGM Configuration for Morphology Discrimination